Cargando…

Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patients

A single dose of bevacizumab reduced the density of angiopoietin-2-positive vessels while improving the infiltration of CD4+ T and CD8+ T cells, and mature dendritic cells in patients with primary triple-negative breast cancer. Our findings provide a rationale for including bevacizumab during neoadj...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boucher, Yves, Kumar, Ashwin S., Posada, Jessica M., Gjini, Evisa, Pfaff, Kathleen, Lipschitz, Mikel, Lako, Ana, Duda, Dan G., Rodig, Scott J., Hodi, F. Stephen, Jain, Rakesh K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242049/ https://www.ncbi.nlm.nih.gov/pubmed/34188163 http://dx.doi.org/10.1038/s41698-021-00197-w

Ejemplares similares

A phase I trial of panobinostat (LBH589) in patients with metastatic melanoma
por: Ibrahim, Nageatte, et al.
Publicado: (2016)

Regression of multifocoal in transit melanoma metastases after palliative resection of dominant masses and 2 years after treatment with ipilimumab
por: Moreira, Raphael B., et al.
Publicado: (2017)

Combining CTLA-4 and angiopoietin-2 blockade in patients with advanced melanoma: a phase I trial
por: Ott, Patrick A, et al.
Publicado: (2021)

Dendritic cell-derived nitric oxide inhibits the differentiation of effector dendritic cells
por: Si, Chuanping, et al.
Publicado: (2016)

Disruption of asxl1 results in myeloproliferative neoplasms in zebrafish
por: Gjini, Evisa, et al.
Publicado: (2019)

Plasmacytoid Dendritic Cell (pDC) Infiltration Correlate with Tumor Infiltrating Lymphocytes, Cancer Immunity, and Better Survival in Triple Negative Breast Cancer (TNBC) More Strongly than Conventional Dendritic Cell (cDC)
por: Oshi, Masanori, et al.
Publicado: (2020)

Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus
por: Domingues, Rosana, et al.
Publicado: (2016)

Dendritic cell inhibition correlates with survival of colorectal cancer patients on bevacizumab treatment
por: Michielsen, Adriana J., et al.
Publicado: (2012)

Dendritic Cells: Behind the Scenes of T-Cell Infiltration into the Tumor Microenvironment
por: Lucarini, Valeria, et al.
Publicado: (2021)

Deciphering tumor-infiltrating dendritic cells in the single-cell era
por: Huang, Qingyu, et al.
Publicado: (2023)

Induction of CD4(+) Regulatory and Polarized Effector/helper T Cells by Dendritic Cells
por: Lutz, Manfred B.
Publicado: (2016)

Desirable cytolytic immune effector cell recruitment by interleukin-15 dendritic cells
por: Van Acker, Heleen H., et al.
Publicado: (2017)

Plasmacytoid Dendritic Cell Infiltration in Acute Myeloid Leukemia
por: Zhu, Lidan, et al.
Publicado: (2020)

Tumor masses support naive T cell infiltration, activation, and differentiation into effectors
por: Thompson, Elizabeth D., et al.
Publicado: (2010)

Lipid Mediators From Timothy Grass Pollen Contribute to the Effector Phase of Allergy and Prime Dendritic Cells for Glycolipid Presentation
por: González Roldán, Nestor, et al.
Publicado: (2019)

Multiple centrosomes enhance migration and immune cell effector functions of mature dendritic cells
por: Weier, Ann-Kathrin, et al.
Publicado: (2022)

Zebrafish Tie-2 shares a redundant role with Tie-1 in heart development and regulates vessel integrity
por: Gjini, Evisa, et al.
Publicado: (2011)

NIK signaling in dendritic cells but not in T cells is required for the development of effector T cells and cell-mediated immune responses
por: Hofmann, Janin, et al.
Publicado: (2011)

Melanoma-infiltrating dendritic cells: Limitations and opportunities of mouse models
por: Klarquist, Jared S., et al.
Publicado: (2012)

Multiplex Tissue Imaging Harmonization: A Multicenter Experience from CIMAC-CIDC Immuno-Oncology Biomarkers Network
por: Akturk, Guray, et al.
Publicado: (2021)

Effector and regulatory dendritic cells display distinct patterns of miRNA expression
por: Lombardi, Vincent, et al.
Publicado: (2017)

Single-cell transcriptomics reveals distinct effector profiles of infiltrating T cells in lupus skin and kidney
por: Dunlap, Garrett S., et al.
Publicado: (2022)

Antigen-Specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic Cells
por: Dhodapkar, Madhav V., et al.
Publicado: (2001)

Breast cancer stem cell RNA-pulsed dendritic cells enhance tumor cell killing by effector T cells
por: Sumransub, Nuttavut, et al.
Publicado: (2020)

Myocarditis Elicits Dendritic Cell and Monocyte Infiltration in the Heart and Self-Antigen Presentation by Conventional Type 2 Dendritic Cells
por: Van der Borght, Katrien, et al.
Publicado: (2018)

Apoptosis of tumor infiltrating effector TIM-3+CD8+ T cells in colon cancer
por: Kang, Chiao-Wen, et al.
Publicado: (2015)

Suppressive effects of the obese tumor microenvironment on CD8 T cell infiltration and effector function
por: Dyck, Lydia, et al.
Publicado: (2022)

Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosis
por: Labidi-Galy, Sana Intidhar, et al.
Publicado: (2012)

Isolated skin infiltration by a blastic plasmacytoid dendritic cell neoplasm
por: Stalder, Grégoire, et al.
Publicado: (2022)

Clinicopathological Correlates of γδ T Cell Infiltration in Triple-Negative Breast Cancer
por: Boissière-Michot, Florence, et al.
Publicado: (2021)

Prolonged contact with dendritic cells turns lymph node‐resident NK cells into anti‐tumor effectors
por: Mingozzi, Francesca, et al.
Publicado: (2016)

PPARγ in dendritic cells and T cells drives pathogenic type-2 effector responses in lung inflammation
por: Nobs, Samuel Philip, et al.
Publicado: (2017)

Expansion of effector and memory T cells is associated with increased survival in recurrent glioblastomas treated with dendritic cell immunotherapy
por: Eoli, Marica, et al.
Publicado: (2019)

Chronic LCMV infection regulates the effector T cell response by inducing the generation of less immunogenic dendritic cells
por: Yoo, Seungbo, et al.
Publicado: (2023)

Brief Communication on Pathologic Assessment of Persistent Stable Metastatic Lesions in Patients Treated With Anti-CTLA-4 or Anti-CTLA-4 + Anti-PD-1 Therapy
por: Buchbinder, Elizabeth I., et al.
Publicado: (2023)

Tumor-infiltrating effector cells of α-galactosylceramide-induced antitumor immunity in metastatic liver tumor
por: Osada, Takuya, et al.
Publicado: (2004)

Tumor-infiltrating mucosal-associated invariant T (MAIT) cells retain expression of cytotoxic effector molecules
por: Sundström, Patrik, et al.
Publicado: (2019)

Cancer-derived cholesterol sulfate is a key mediator to prevent tumor infiltration by effector T cells
por: Tatsuguchi, Takaaki, et al.
Publicado: (2022)

Correction: Suppressive effects of the obese tumor microenvironment on CD8 T cell infiltration and effector function
por: Dyck, Lydia, et al.
Publicado: (2022)

STAT3 signaling contributes to the high effector activities of interleukin-15-derived dendritic cells
por: Okada, Starlyn, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hq7vnkpm6mp21llril8hl2is5b